share_log

B of A Securities Initiates Coverage On Amphastar Pharma With Neutral Rating, Announces Price Target of $63

B of A Securities Initiates Coverage On Amphastar Pharma With Neutral Rating, Announces Price Target of $63

Bof A Securities以中性评级启动对Amphastar Pharma的报道,宣布目标股价为63美元
Benzinga ·  2023/11/17 08:12

B of A Securities analyst Jason Gerberry initiates coverage on Amphastar Pharma (NASDAQ:AMPH) with a Neutral rating and announces Price Target of $63.

Bof A Securities分析师杰森·格伯里以中性评级开始对Amphastar Pharma(纳斯达克股票代码:AMPH)进行报道,并宣布目标股价为63美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发